Article
Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
Journal of virology - 1 Dec 1996
Hehir K M, Armentano D, Cardoza L M, Choquette T L, Berthelette P B, White G A, Couture L A, Everton M B, Keegan J, Martin J M, Pratt D A, Smith M P, Smith A E, Wadsworth S C
Abstract excerpt
Adenovirus (Ad) vectors for gene therapy are made replication defective by deletion of E1 region genes. For isolation, propagation, and large-scale production of such vectors, E1 functions are supplied in trans from a stable cell line. Virtually all Ad vectors used for clinical studies are produced in the 293 cell, a human embryonic kidney cell line expressing E1 functions from an integrated segment of the left...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
